new glp-1 medications Popular may have health benefits that extend beyond weight loss and blood sugar control, a study finds Decoding GLP-1 Weight Loss Medications

doi: 10.1021/acs.analchem.5b02781

[DOI] [PubMed] [Google Scholar] Smith J

We closely follow the latest clinical trials and studies on the medications we recommend, including semaglutide

We refer readers to section XVI.C.2

The clinical manifestations of PD are diverse, encompassing a range of motor symptoms, such as bradykinesia, resting tremor, rigidity, and postural instability

In March 2026, Structure reported 44-week topline data from the ACCESS II Phase 2 study, showing placebo-adjusted weight loss of up to 16.3%, which the company described as the highest efficacy demonstrated among oral GLP-1 receptor agonists at that time point